Rankings
▼
Calendar
ALKS Q4 2017 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$275M
+29.0% YoY
Gross Profit
$237M
86.0% margin
Operating Income
$6M
2.1% margin
Net Income
-$10M
-3.6% margin
EPS (Diluted)
$-0.06
QoQ Revenue Growth
+26.7%
Cash Flow
Operating Cash Flow
$36M
Free Cash Flow
$18M
Stock-Based Comp.
$21M
Balance Sheet
Total Assets
$1.8B
Total Liabilities
$594M
Stockholders' Equity
$1.2B
Cash & Equivalents
$191M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$275M
$214M
+29.0%
Gross Profit
$237M
$179M
+32.7%
Operating Income
$6M
-$24M
+124.8%
Net Income
-$10M
-$21M
+53.7%
← FY 2017
All Quarters
Q1 2018 →